PRESS RELEASE: Zylaria™ Exhibits Strong Neuroprotective Activity by Improving GABA Release in New Study

PRESS RELEASE: NuLiv Science Proudly Announces B-Corp Status

New human clinical study on InnoSlim® supports adiponectin and AMPK activation

NuLiv Science Receives Positive Clinical Study Results On Its 90-Day Toxicity Study For ASTRAGIN®

NuLiv Science Awarded Natural Product Number (NPN) From Health Canada To Expand Nutraceutical Ingredient, ASTRAGIN®, Into Canadian Market